Global Information
회사소개 | 문의

세계의 인공장기 시장 분석과 예측(2018-2023년) : 장기 종류, 기술 종류, 경쟁 상황, 파이프라인 제품 데이터, 주요 12개국 데이터

Global Artificial Organs Market: Focus on Organ Type, Technology Type, Competitive Landscape, Pipeline Products Data, and 12 Countries Data - Analysis and Forecast 2018-2023

리서치사 BIS Research Inc.
발행일 2018년 12월 상품 코드 762880
페이지 정보 영문 255 Pages
가격
US $ 5,000 ₩ 5,717,000 Unprintable PDF by E-mail (Single User License)
US $ 5,500 ₩ 6,288,000 Hard Copy
US $ 6,500 ₩ 7,432,000 Printable PDF by E-mail (Single Site License)
US $ 8,000 ₩ 9,147,000 Printable PDF and Excel by E-mail (Enterprise-wide License)


세계의 인공장기 시장 분석과 예측(2018-2023년) : 장기 종류, 기술 종류, 경쟁 상황, 파이프라인 제품 데이터, 주요 12개국 데이터 Global Artificial Organs Market: Focus on Organ Type, Technology Type, Competitive Landscape, Pipeline Products Data, and 12 Countries Data - Analysis and Forecast 2018-2023
발행일 : 2018년 12월 페이지 정보 : 영문 255 Pages

세계의 인공장기 시장 규모는 2023년까지 53억 7,000만 달러에 달할 것으로 예측됩니다.

세계의 인공장기(Artificial Organs) 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 각 부문·지역별 시장 분석과 예측, 경쟁 분석 및 주요 기업 개요 등을 제공합니다.

주요 요약

제1장 시장 개요

  • 서론
  • 이식 및 인공장기 요구 고조
  • 장기의 수요와 공급 격차 확대
  • 인공장기의 출현 및 현황
  • 인공장기의 영향 : 장단점
  • 인공장기의 미래
  • 세계 시장 상황
  • 예측의 가정과 제한사항

제2장 시장 역학

  • 개요
  • 영향 분석
  • 시장 성장 촉진요인
  • 과제
  • 기회

제3장 경쟁 상황

  • 주요 시장 발전과 전략
  • 산업의 매력

제4장 규제 체계

  • 국제적인 법적 요건과 체계
  • 아메리카의 법적 요건과 체계
  • 유럽의 법적 요건과 체계
  • 아시아태평양의 법적 요건과 체계

제5장 세계의 인공장기 시장 : 장기 종류별

  • 개요
  • 인공췌장
  • 인공심장
  • 인공귀
  • 인공눈
  • 인공방광

제6장 세계의 인공장기 시장 : 기술별

  • 개요
  • 웨어러블 기술
  • 이식형 기술

제7장 세계의 인공장기 시장 : 지역별

  • 각국의 성장 가능성 분석
  • 세계 시장
  • 북미
  • 유럽
  • 아시아태평양
  • 기타(RoW)

제8장 기업 개요

  • 개요
  • Advanced Bionics AG and affiliates
  • Boston Scientific Corporation
  • CARMAT
  • Cochlear Ltd.
  • Dexcom, Inc.
  • Insulet Corporation
  • KeraMed, Inc.
  • MED-EL
  • Medtronic plc
  • Oticon Medical
  • PIXIUM VISION
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • SynCardia Systems, LLC
  • Tandem Diabetes Care, Inc.

제9장 조사 범위와 방법

KSM 19.01.11

List of Tables

  • Table 1: Global Artificial Organs Market, 2017 and 2023
  • Table 1.1: Total Number of Donors in Different Countries in 2015 [Data presented in absolute number and rate per million inhabitants (pmp)]
  • Table 1.2: Total Number of Organ Transplantation (Tx) in Different Countries in 2015 [Data presented in absolute number and rate per million inhabitants (pmp)]
  • Table 2.1: Impact Analysis of Market Drivers
  • Table 2.2: Impact Analysis of Market Challenges
  • Table 2.3: Percentage of Total Regional Population Aged 65 Years & Above: 2015 & 2030
  • Table 2.4: Contribution of Risk Factors to Lifestyle Diseases (Percentage of Individual Population Attributable Fraction)
  • Table 2.5: Disease Burden Due to Common Lifestyle Diseases across Different Regions, 2016
  • Table 2.6: Funding Initiatives by Government and Research institutes
  • Table 2.7: Funding Initiatives by Private and Public Companies
  • Table 2.8: Research and Development Expenses in 2016 and 2017 ($Million)
  • Table 2.9: Post-Operational Consequences of SynCardia TAH Implantation
  • Table 2.10: Post-Operational Consequences of Total Artificial Heart (TAH) Implantation
  • Table 4.1: Regulatory Authorities/Associations/Consortiums for Medical Devices in the Americas
  • Table 4.2: Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
  • Table 4.3: Regulatory authorities/associations/consortiums for Medical Devices in Asia-Pacific
  • Table 5.1: Pipeline Products of Artificial Pancreas
  • Table 5.2: List of Companies and Product Offerings in Artificial Organs Market (by Ear)
  • Table 5.3: List of Companies and Product Offerings in Artificial Organs Market (by Eye)
  • Table 5.4: Pipeline Products of Artificial Eye
  • Table 6.1: List of Artificial Organs with Wearable Technologies
  • Table 6.2: List of Artificial Organs with Implantable Technologies

List of Figures

  • Figure: 1: Types of Artificial Organs
  • Figure: 2: Global Artificial Organs Market Snapshot
  • Figure: 3: Impact of Market Drivers and Market Restraints, 2017
  • Figure: 4: Share of Key Developments and Strategies, January 2014-August 2018
  • Figure: 5: Market Share of Key Companies, 2016 and 2017
  • Figure: 6: Global Artificial Organs Market Share (by Organ Type), 2017-2023
  • Figure: 7: Global Artificial Organs Market Share (by Technology Type), 2017-2023
  • Figure: 8: Global Artificial Organs Market Share (by Region), 2017 and 2023
  • Figure: 1.1: Factors Playing Significant Role in Demand and Supply of Organs
  • Figure: 1.2: Evolution of Artificial Organs
  • Figure: 1.3: Advantages and Disadvantages of Artificial Organs
  • Figure: 1.4: Global Artificial Organs Market, 2017-2023
  • Figure: 2.1: Market Dynamics
  • Figure: 2.2: Projected Global Geriatric Population Aged 60 Years and Above (Billion), 1900-2100
  • Figure: 2.3: Number of Donors Recovered and Patients Waiting at the Year-end vs. Number of Transplants Performed, 2010-2017
  • Figure: 2.4: Function of Multi Organs-on-Chips
  • Figure: 3.1: Competitive Landscape (January 2010-October 2018)
  • Figure: 3.2: Share of Key Developments and Strategies, January 2014-August 2018
  • Figure: 3.3: Product Approvals (by Company), January 2010-August 2018
  • Figure: 3.4: Agreements, Collaborations, and Partnerships (by Company), January 2010-August 2018
  • Figure: 3.5: Funding Activities (by Company), January 2010-August 2018
  • Figure: 3.6: Product Launches and Developments (by Company), January 2010-August 2018
  • Figure: 3.7: Acquisitions (by Company), January 2010-August 2018
  • Figure: 3.8: Market Share Analysis for Global Artificial Organs Market, 2016
  • Figure: 3.9: Market Share Analysis for Global Artificial Organs Market, 2017
  • Figure: 3.10: Growth Share Matrix for Global Artificial Organs Market (by Organ Type), 2017
  • Figure: 3.11: Bargaining Power of Suppliers: Overall Impact
  • Figure: 3.12: Bargaining Power of Buyers: Overall Impact
  • Figure: 3.13: Threat of New Entrants: Overall Impact
  • Figure: 3.14: Threat of Substitute Products: Overall Impact
  • Figure: 3.15: Intensity of Competitive Rivalry: Overall Impact
  • Figure: 5.1: Artificial Organs Market Segmentation (by Organ Type)
  • Figure: 5.2: Global Artificial Organs Market (by Organ Type), 2017-2023
  • Figure: 5.3: Mechanism of Action of Artificial Pancreas
  • Figure: 5.4: Global Artificial Organs Market (by Pancreas), 2017-2023
  • Figure: 5.5: Revenue Forecast of Companies with Artificial Pancreas in Pipeline, 2019-2023
  • Figure: 5.6: Mechanism of Action of TAH
  • Figure: 5.7: Key Points about AbioCor
  • Figure: 5.8: Global Artificial Organs Market (by Heart), 2017-2023
  • Figure: 5.9: Sales of SynCardia System, LLC's TAH (by Volume), 2009-2023
  • Figure: 5.10: Mechanism of Action of Cochlear Implants
  • Figure: 5.11: Global Artificial Organs Market (by Ear), 2017-2023
  • Figure: 5.12: Mechanism of Action of Artificial Retina
  • Figure: 5.13: Global Artificial Organs Market (by Eye), 2017-2023
  • Figure: 5.14: Key Points on AMS 800 Urinary Control System
  • Figure: 5.15: Global Artificial Organs Market (by Urinary Bladder), 2017-2023
  • Figure: 6.1: Artificial Organs Market Segmentation (by Technology)
  • Figure: 6.2: Global Artificial Organs Market (by Technology), 2017-2023
  • Figure: 6.3: Global Artificial Organs Market (by Wearable Technologies), 2017-2023
  • Figure: 6.4: Global Wearable Artificial Organs Market (by Organ Types), 2017-2023
  • Figure: 6.5: Global Artificial Organs Market (by Implantable Technologies), 2017-2023
  • Figure: 6.6: Global Implantable Artificial Organs Market (by Organ Type), 2017-2023
  • Figure: 7.1: Contribution of Different Artificial Organs in Different Geographical Regions, 2017
  • Figure: 7.2: Artificial Pancreas: Analysis of Potential Growth Factors Across Different Regions
  • Figure: 7.3: Artificial Heart: Analysis of Potential Growth Factors across Different Regions
  • Figure: 7.4: Artificial Eye and Artificial Ear: Analysis of Potential Growth Factors across Different Regions
  • Figure: 7.5: Global Artificial Organs Market (by Region), 2017 and 2023
  • Figure: 7.6: North America: Artificial Organs Market, 2017-2023
  • Figure: 7.7: North America: Market Dynamics
  • Figure: 7.8: North America: Artificial Organs Market (by Country), 2017-2023
  • Figure: 7.9: Number of Donors Recovered and Transplants Performed per Year vs. Patients Waiting at Year End
  • Figure: 7.10: The U.S.: Artificial Organs Market, 2017-2023
  • Figure: 7.11: Canada: Artificial Organs Market, 2017-2023
  • Figure: 7.12: Europe: Artificial Organs Market, 2017-2023
  • Figure: 7.13: Europe: Market Dynamics
  • Figure: 7.14: Europe: Artificial Organs Market (by Country), 2017-2023
  • Figure: 7.15: Germany: Artificial Organs Market, 2017-2023
  • Figure: 7.16: The U.K.: Artificial Organs Market, 2017-2023
  • Figure: 7.17: France: Artificial Organs Market, 2017-2023
  • Figure: 7.18: Number of Patients on an Organ Donation Waiting List in Italy in 2017
  • Figure: 7.19: Italy: Artificial Organs Market, 2017-2023
  • Figure: 7.20: Sweden: Artificial Organs Market, 2017-2023
  • Figure: 7.21: Rest-of-Europe: Artificial Organs Market, 2017-2023
  • Figure: 7.22: Asia-Pacific: Artificial Organs Market, 2017-2023
  • Figure: 7.23: Asia-Pacific: Market Dynamics
  • Figure: 7.24: Asia-Pacific: Artificial Organs Market (by Country), 2017-2023
  • Figure: 7.25: Japan: Artificial Organs Market, 2017-2023
  • Figure: 7.26: China: Artificial Organs Market, 2017-2023
  • Figure: 7.27: Australia: Artificial Organs Market, 2017-2023
  • Figure: 7.28: India: Artificial Organs Market, 2017-2023
  • Figure: 7.29: Singapore: Artificial Organs Market, 2017-2023
  • Figure: 7.30: Rest of Asia-Pacific: Artificial Organs Market, 2017-2023
  • Figure: 7.31: Rest-of-the-World: Artificial Organs Market, 2017-2023
  • Figure: 7.32: Rest-of-the-World: Market Dynamics
  • Figure: 7.33: Rest-of-the-World: Artificial Organs Market (by Region), 2017-2023
  • Figure: 7.34: Latin-America: Artificial Organs Market, 2017-2023
  • Figure: 7.35: Middle-East and Africa: Artificial Organs Market, 2017-2023
  • Figure: 8.1: Shares of Key Company Profiles
  • Figure: 8.2: Advanced Bionics AG and affiliates Product Portfolio for Artificial Organs Market
  • Figure: 8.3: Advanced Bionics AG and affiliates: SWOT Analysis
  • Figure: 8.4: Boston Scientific Corporation: Product Portfolio for Artificial Organs Market
  • Figure: 8.5: Boston Scientific Corporation: Overall Financials, 2015-2017
  • Figure: 8.6: Boston Scientific Corporation: Revenue (by Segment), 2015-2017
  • Figure: 8.7: Boston Scientific Corporation: Revenue (by Region), 2015-2017
  • Figure: 8.8: Boston Scientific Corporation: R&D Expenditure (2015-2017)
  • Figure: 8.9: Boston Scientific Corporation: Revenue Forecast, 2014-2020
  • Figure: 8.10: Boston Scientific Corporation: SWOT Analysis
  • Figure: 8.11: CARMAT Product Portfolio for Artificial Organs Market
  • Figure: 8.12: CARMAT: SWOT Analysis
  • Figure: 8.13: Cochlear Ltd.: Product Portfolio for Artificial Organs Market
  • Figure: 8.14: Cochlear Ltd.: Overall Financials, 2016-2018
  • Figure: 8.15: Cochlear Ltd.: Revenue (by Segment), 2016-2018
  • Figure: 8.16: Cochlear Ltd.: Revenue (by Region), 2016-2018
  • Figure: 8.17: Cochlear Ltd.: R&D Expenditure
  • Figure: 8.18: Cochlear Ltd.: Revenue Forecast, 2015-2020
  • Figure: 8.19: Cochlear Ltd.: SWOT Analysis
  • Figure: 8.20: Dexcom, Inc.: Product Portfolio for Artificial Organs Market
  • Figure: 8.21: Dexcom, Inc.: Overall Financials, 2015-2017
  • Figure: 8.22: Dexcom, Inc.: Revenue (by Region), 2015-2017
  • Figure: 8.23: Dexcom, Inc.: R&D Expenditure (2015-2017)
  • Figure: 8.24: Dexcom, Inc.: Revenue Forecast, 2014-2020
  • Figure: 8.25: Dexcom, Inc.: SWOT Analysis
  • Figure: 8.26: Insulet Corporation: Product Portfolio for Artificial Organs Market
  • Figure: 8.27: Insulet Corporation: Overall Financials, 2015-2017
  • Figure: 8.28: Insulet Corporation: Revenue (by Region), 2015-2017
  • Figure: 8.29: Insulet Corporation: R&D Expenditure (2015-2017)
  • Figure: 8.30: Insulet Corporation: Revenue Forecast, 2014-2020
  • Figure: 8.31: Insulet Corporation: SWOT Analysis
  • Figure: 8.32: KeraMed, Inc. Product Portfolio for Artificial Organs Market
  • Figure: 8.33: KeraMed, Inc.: SWOT Analysis
  • Figure: 8.34: MED-EL Product Portfolio for Artificial Organs Market
  • Figure: 8.35: MED-EL: SWOT Analysis
  • Figure: 8.36: Medtronic plc: Product Portfolio for Artificial Organs Market
  • Figure: 8.37: Medtronic plc: Overall Financials, 2016-2018
  • Figure: 8.38: Medtronic plc: Revenue (by Segment), 2016-2018
  • Figure: 8.39: Medtronic plc: Revenue (by Region), 2016-2018
  • Figure: 8.40: Medtronic plc: R&D Expenditure
  • Figure: 8.41: Medtronic plc: Revenue Forecast, 2015-2020
  • Figure: 8.42: Medtronic plc: SWOT Analysis
  • Figure: 8.43: Oticon Medical Product Portfolio for Artificial Organs Market
  • Figure: 8.44: Oticon Medical: SWOT Analysis
  • Figure: 8.45: PIXIUM VISION Product Portfolio for Artificial Organs Market
  • Figure: 8.46: PIXIUM VISION: SWOT Analysis
  • Figure: 8.47: Retina Implant AG Product Portfolio for Artificial Organs Market
  • Figure: 8.48: Retina Implant AG: SWOT Analysis
  • Figure: 8.49: Second Sight Medical Products, Inc.: Product Portfolio for Artificial Organs Market
  • Figure: 8.50: Second Sight Medical Products, Inc.: Overall Financials, 2016-2018
  • Figure: 8.51: Second Sight Medical Products, Inc.: Revenue (by Region), 2016-2018
  • Figure: 8.52: Second Sight Medical Products, Inc.: R&D Expenditure
  • Figure: 8.53: Second Sight Medical Products, Inc.: SWOT Analysis
  • Figure: 8.54: SynCardia Systems, LLC Product Portfolio for Artificial Organs Market
  • Figure: 8.55: SynCardia Systems, LLC: SWOT Analysis
  • Figure: 8.56: Tandem Diabetes Care, Inc. Product Portfolio for Artificial Organs Market
  • Figure: 8.57: Tandem Diabetes Care, Inc.: Overall Financials, 2015-2017
  • Figure: 8.58: Tandem Diabetes Care, Inc.: R&D Expenditure (2015-2017)
  • Figure: 8.59: Tandem Diabetes Care, Inc.: Revenue Forecast, 2014-2020
  • Figure: 8.60: Tandem Diabetes Care, Inc.: SWOT Analysis
  • Figure: 9.1: Global Artificial Organs Market Segmentation
  • Figure: 9.2: Global Artificial Organs Market Research Methodology
  • Figure: 9.3: Primary Research
  • Figure: 9.4: Secondary Research
  • Figure: 9.5: Data Triangulation
  • Figure: 9.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure: 9.7: Top-down Approach (Segment-wise Analysis)
  • Figure: 9.8: Assumptions and Limitations
  • Figure: 9.9: Considered Factors for Data Prediction and Modelling

"Global Artificial Organs Market to Reach $5.37 Billion by 2023, Reports BIS Research"

The medical device industry is a multi-billion dollar market consisting of various verticals aimed at prolonging a patient's lives and improving the overall quality of lives. Foremost among the medical device innovation was the development of artificial organs as a substitute of organ transplants. Rapidly aging population worldwide and increased prevalence of lifestyle diseases have led to an increased number of people suffering from organ failures. However, the unavailability of adequate organs and huge scarcity of organ donors have resulted in a global concern regarding organ shortage. Thousands of people die every year while waiting for some vital organ transplantation. The advent of artificial organs as the potential replacement of organ transplants has given a new ray of hope to resolve the organ shortage crisis. Artificial organs are man-made engineered devices that can mimic vital organ function of the body. It is either an implantable or a wearable medical device or a combination of two and is designed based on mechanical, optical, electrical, and biophysical properties of the living organs.

The market analysis of global artificial organs includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis. Presently, the artificial organs market can be categorized into five major organ types that are commercially available. It includes artificial pancreas, heart, ear, eye, and urinary bladder. Considerable number of other artificial organs are presently in the pipeline, including artificial lungs, liver, kidney, and trachea that are expected to be commercialized in the upcoming years. Based on technology, the artificial organs market can further be sub-segmented into two broad categories: implantable devices and non-implantable devices. Geographically, the market can be segmented into five distinct regions including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the global artificial organs market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations into oncology fields. The scope of the report is centered upon conducting a detailed study of the solutions allied with the global artificial organs market, which involves devices of different organ types. The global artificial organ market is segmented into three different parts: organ type, technology, and region. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global artificial organs market and assesses the factors governing the same. Opportunity matrix and detailed product mapping have also been included in the report. The market (by region) has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and the recent developments that have taken place, have been discussed.

The answers to the following key questions can be derived from this report:

  • What are the artificial organs' key features which make them a suitable substitute to organ transplants?
  • What are the advantages of artificial organs over conventional organ transplants?
  • How did the artificial organs market evolve, and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global artificial organs market?
  • What are the key developmental strategies which are implemented by the key players to stand out in this market?
  • What are the leading companies dominating the global artificial organs market?
  • How many types of artificial organs are available in the market, and which are the companies offering the artificial organs?
  • Based on organ type, which artificial organ type is anticipated to witness massive rise in the demand in the forecast period and in which region?
  • What are the different implantable and wearable artificial organs available in the market? Which technology between the two is leading and why?
  • What are investors' perceptions about the global artificial organs market? Also, what is the funding scenario of the market?
  • What are the key companies which made substantial investments to aid technological advancements in the market?
  • What are the regulations pertaining to the global artificial organs market? What are initiatives implemented by different government bodies to combat the shortage of organ crisis?
  • What was the market value of the leading segments and sub-segments of the global artificial organs market?
  • How will each segment of the global artificial organs market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2023?
  • How will the industry evolve during the forecast period 2018-2023?
  • Which region will contribute to the highest sales of the global artificial organs market during the forecast period?
  • Which region carries the potential for the significant expansion of key companies for different artificial organ types?

The key players that have been contributing significantly into the global artificial organs market include: Advanced Bionics AG and affiliates, Boston Scientific Corporation, CARMAT, Cochlear Ltd., Dexcom, Inc., Insulet Corporation, KeraMed, Inc., MED-EL, Medtronic plc, Oticon Medical, PIXIUM VISION, Retina Implant AG, Second Sight Medical Products, Inc., SynCardia Systems, LLC, and Tandem Diabetes Care, Inc., among others.

Executive Summary

Organ transplantation is often regarded as a life-saving procedure for patients who are in urgent need to replace their degenerated or damaged organs. With growing geriatric population worldwide and increase in the prevalence of variety of diseases, the demand for organ transplants is increasing rapidly at a global level. According to the Global Observatory on Donation and Transplantation (GODT) analysis from 2010 transplant activity, there were 106,879 solid organ transplants performed in 2010, including 73,179 kidney transplants, 21,602 liver transplants, 5,582 heart transplants, 3,927 lung transplants, 2,362 pancreas transplants, and 227 small bowel. Despite enormous technological advancements in the field of transplantation, shortage of organs poses a critical challenge worldwide. Everyday there are thousands of people across the world waiting for organ transplants to get their non-functional organs replaced and often end up dying in the lack of a suitable organ donor. The U.S. Government Information on Organ Donation and Transplantation states that every ten minutes there is an addition of another person on the national transplant waiting list and 20 people die each day waiting for a transplant. Therefore, in order to meet the rising demand for organ transplants, there is a constant urge to develop an alternate transplantation option. The introduction of artificial organs in the medical device industry brought a new ray of hope to solve the global crisis of organ shortage.

Artificial organs are engineered medical devices that can act as a substitute of organ transplant. These are the medical device solutions which are either implantable or wearable and can mimic the vital functions of critical body organs. Significant number companies and research institutes from across the globe are working actively to develop various artificial organs with the aim to eliminate the scarcity of organ donors. Currently, there are five major types of artificial organs available in the market including ear, eye, pancreas, heart, and urinary bladder, though there are several other products in the developmental stages.

The purpose of the study is to gain a holistic view of the global artificial organs market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the devices allied with the artificial organs market including both commercialized products as well as products that are in the pipeline. The global artificial organs market is segmented into three different parts: organ type, technology, and region. The global market value was estimated using these three different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation.

The global artificial organs market was estimated at $1.6 billion in 2017 and is anticipated to reach $5.37 billion by 2023. Among the different artificial organs available in the market, artificial ear contributed to the highest market share of the global artificial organs market in 2017. However, artificial pancreas is expected to witness the highest CAGR during the forecast period between 2018 and 2023. The presence of several artificial pancreas products in the pipeline attributes to the highest CAGR displayed by the artificial pancreas market. Based on technology, implantable devices occupied higher market share as compared to wearable devices, whereas wearable devices demonstrated the potential to register higher growth rate than implantable technology.

The global artificial organs market is segmented by the geographical regions into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). The RoW region comprises Latin America and Middle East and Africa. North America is the leading contributor to the global artificial organs market with a contribution of more than 45% total artificial organs market share in 2017. The North America market is also expected to grow at a CAGR of 24.16% in the forecast period 2018-2023. The global artificial organs market is majorly dominated by the U.S. and the European players. However, several emerging countries of Asia-Pacific and Latin America displayed high potential to witness robust growth rate during the period. The Australia-based company, Cochlear Ltd. offering artificial ears contributed more than 50% of the market value in 2017.

The key players who have significant contributions to the global artificial organs market are Advanced Bionics AG and affiliates, Boston Scientific Corporation, CARMAT, Cochlear Ltd., Dexcom, Inc., Insulet Corporation, KeraMed, Inc., MED-EL, Medtronic plc, Oticon Medical, PIXIUM VISION, Retina Implant AG, Second Sight Medical Products, Inc., SynCardia Systems, LLC, and Tandem Diabetes Care, Inc., among others.

Table of Contents

Executive Summary

1. Market Overview

  • 1.1. Introduction
  • 1.2. Transplantation and Rising Need for Artificial Organs
  • 1.3. The Widening Gap between Demand and Supply of Organs
  • 1.4. Advent of Artificial Organs and Current Status
  • 1.5. Impact of Artificial Organs: Advantages and Disadvantages
  • 1.6. The Future of Artificial Organs
  • 1.7. Global Market Scenario
  • 1.8. Assumptions and Limitations

2. Market Dynamics

  • 2.1. Overview
  • 2.2. Impact Analysis
  • 2.3. Market Drivers
    • 2.3.1. Growing Geriatric Population
    • 2.3.2. Rising Incidence of Lifestyle Diseases
    • 2.3.3. Increasing Need for Organ Transplantation and Substantial Shortage of Available Donors
    • 2.3.4. Persistent Support from Government and Non-Governmental Organizations
    • 2.3.5. Technological Advancements and Increased R&D Expenditure
  • 2.4. Challenges
    • 2.4.1. Risks of Device Malfunction and Other Related Concerns
    • 2.4.2. Immune Barrier to Artificial Organ
    • 2.4.3. Stringent Regulation and Poor Reimbursement Coverage
    • 2.4.4. Exorbitant Cost of Artificial Organs
  • 2.5. Opportunities
    • 2.5.1. Application of Advanced Biomaterials in Artificial Organs
    • 2.5.2. Organ-on-Chips Technology
    • 2.5.3. Monitoring Artificial Organs Using Precise Diagnostics

3. Competitive Landscape

  • 3.1. Key Developments and Strategies
    • 3.1.1. Product Approvals
    • 3.1.2. Agreements, Collaborations and Partnerships
    • 3.1.3. Funding
    • 3.1.4. Product Launches and Developments
    • 3.1.5. Acquisition
    • 3.1.6. Other Strategies
    • 3.1.7. Market Share Analysis
    • 3.1.8. Growth Share Analysis (by Organ Type)
  • 3.2. Industry Attractiveness
    • 3.2.1. Bargaining Power of Suppliers
    • 3.2.2. Bargaining Power of Buyers
    • 3.2.3. Threat of New Entrants
    • 3.2.4. Threat of Substitute Products
    • 3.2.5. Intensity of Competitive Rivalry

4. Regulatory Framework

  • 4.1. Legal Requirements and Framework at International Level
    • 4.1.1. International Federation for Artificial Organs (IFAO)
    • 4.1.2. World Health Organization (WHO)
  • 4.2. Legal Requirements and Framework in the Americas
    • 4.2.1. American Society for Artificial Internal Organs (ASAIO)
    • 4.2.2. American Society of Transplantation (AST)
    • 4.2.3. American Chemical Society (ACS)
    • 4.2.4. United States Department of Health and Human Services (HHS)
  • 4.3. Legal Requirements and Framework in Europe
    • 4.3.1. European Society for Artificial Organs (ESAO)
    • 4.3.2. European Society of Organ Transplantation (ESOT)
    • 4.3.3. British Transplantation Society (BTS)
    • 4.3.4. European Society for Bone Marrow and Transplantation (EBMT)
    • 4.3.5. European Commission (EC)
  • 4.4. Legal Requirements and Framework in Asia-Pacific
    • 4.4.1. Asia-Pacific Society of Artificial Organs (ASPAO)
    • 4.4.2. Organ and Tissue Authority (OTA)
    • 4.4.3. Japanese Society for Artificial Organ (JSAO)
    • 4.4.4. Society for Biomaterials and Artificial Organs

5. Global Artificial Organs Market (by Organ Type)

  • 5.1. Overview
  • 5.2. Artificial Pancreas
  • 5.3. Artificial Heart
  • 5.4. Artificial Ear
  • 5.5. Artificial Eye
  • 5.6. Artificial Urinary Bladder

6. Global Artificial Organs Market (by Technology)

  • 6.1. Overview
  • 6.2. Wearable Technologies
  • 6.3. Implantable Technologies

7. Global Artificial Organs Market (by Region)

  • 7.1. Global Artificial Organs Market: Analysis of Growth Potential of Different Countries
  • 7.2. Global Overview
  • 7.3. North America
    • 7.3.1. The U.S.
    • 7.3.2. Canada
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. The U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Sweden
    • 7.4.6. Rest-of-Europe
  • 7.5. Asia-Pacific
    • 7.5.1. Japan
    • 7.5.2. China
    • 7.5.3. Australia
    • 7.5.4. India
    • 7.5.5. Singapore
    • 7.5.6. Rest-of-Asia-Pacific
  • 7.6. Rest-of-the-World
    • 7.6.1. Latin America
    • 7.6.2. Middle East & Africa

8. Company Profiles

  • 8.1. Overview
  • 8.2. Advanced Bionics AG and affiliates
    • 8.2.1. Company Overview
    • 8.2.2. Role of Advanced Bionics AG and affiliates in the Artificial Organs Market
    • 8.2.3. SWOT Analysis
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Role of Boston Scientific Corporation in the Artificial Organs Market
    • 8.3.3. Financials
      • 8.3.3.1. Key Insights about Financial Health of the Company
    • 8.3.4. SWOT Analysis
  • 8.4. CARMAT
    • 8.4.1. Company Overview
    • 8.4.2. Role of CARMAT in the Artificial Organs Market
    • 8.4.3. SWOT Analysis
  • 8.5. Cochlear Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Role of Cochlear Ltd. In the Artificial Organs Market
    • 8.5.3. Financials
    • 8.5.4. Key Insights about Financial Health of the Company
    • 8.5.5. SWOT Analysis
  • 8.6. Dexcom, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Role of Dexcom, Inc. in the Artificial Organs Market
    • 8.6.3. Financials
    • 8.6.4. Key Insights about Financial Health of the Company
    • 8.6.5. SWOT Analysis
  • 8.7. Insulet Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Role of Insulet Corporation in the Artificial Organs Market
    • 8.7.3. Financials
      • 8.7.3.1. Key Insights about Financial Health of the Company
    • 8.7.4. SWOT Analysis
  • 8.8. KeraMed, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Role of KeraMed, Inc. in the Artificial Organs Market
    • 8.8.3. SWOT Analysis
  • 8.9. MED-EL
    • 8.9.1. Company Overview
    • 8.9.2. Role of MED-EL in the Artificial Organs Market
    • 8.9.3. SWOT Analysis
  • 8.10 Medtronic plc
    • 8.10.1. Company Overview
    • 8.10.2. Role of Medtronic plc in the Artificial Organs Market
    • 8.10.3. Financials
      • 8.10.3.1. Key Insights about Financial Health of the Company
    • 8.10.4. SWOT Analysis
  • 8.11 Oticon Medical
    • 8.11.1. Company Overview
    • 8.11.2. Role of Oticon Medical in the Artificial Organs Market
    • 8.11.3. SWOT Analysis
  • 8.12 PIXIUM VISION
    • 8.12.1. Company Overview
    • 8.12.2. Role of PIXIUM VISION in the Artificial Organs Market
    • 8.12.3. SWOT Analysis
  • 8.13 Retina Implant AG
    • 8.13.1. Company Overview
    • 8.13.2. Role of Retina Implant AG in the Artificial Organs Market
    • 8.13.3. SWOT Analysis
  • 8.14 Second Sight Medical Products, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Role of Second Sight Medical Products, Inc. in the Artificial Organs Market
    • 8.14.3. Financials
      • 8.14.3.1. Key Insights about Financial Health of the Company
    • 8.14.4. SWOT Analysis
  • 8.15 SynCardia Systems, LLC
    • 8.15.1. Company Overview
    • 8.15.2. Role of SynCardia Systems, LLC in the Artificial Organs Market
    • 8.15.3. SWOT Analysis
  • 8.16 Tandem Diabetes Care, Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Role of Tandem Diabetes Care, Inc. in the Artificial Organs Market
    • 8.16.3. Financials
      • 8.16.3.1. Key Insights about Financial Health of the Company
    • 8.16.4. SWOT Analysis

9. Research Scope and Methodology

  • 9.1. Report Scope
  • 9.2. Global Artificial Organs Market: Research Methodology
Back to Top
전화 문의
F A Q
 
BCC Research